Clinical trial

A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

NCT00191919

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-05-01

PhasePHASE3

Study timeline

Study start (unknown)2005-05-01Date precision: month

Registry last updated2007-01-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Depressive Disorder, Majorunresolved

Interventions

Duloxetine HydrochlorideDRUG · verified · RxNorm: duloxetine hydrochloride

PlaceboDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Boehringer Ingelheimcollaborator

Mapped research locations

ParisFrance1 BerlinGermany1 PragueCzechia1 ToulouseFrance1 LeuvenBelgium1 MünchenGermany1 RennesFrance1 LeipzigGermany1 BratislavaSlovakia1 HelsinkiFinland1 TurkuFinland1 Freiburg im BreisgauGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00191919 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.